PMC10264131_01
ICU treatment summary. d/c: discontinued; ICU: intensive care unit.
CRICC2023-2000781.001.jpg
PMC10264131_01_CRICC2023-2000781.001.jpg
fig1
Supportive treatment (fluid resuscitation, antibiotic therapy, mechanical ventilation, norepinephrine, and dobutamine) was initiated and adapted from the surviving sepsis campaign-2016 guideline (shown in Figure 1).
Changes in clinical and biochemical data before and after treatment with the oXiris  membrane. Body temperature, vasopressors doses, PCT, CRP, and IL-6 levels related to the use of the oXiris  membrane. CRP: C reaction protein; PCT: procalcitonin.
CRICC2023-2000781.002.jpg
PMC10264131_01_CRICC2023-2000781.002.jpg
fig2
The inflammatory biomarkers and doses of vasopressors rapidly declined (shown in Figure 2 and Table 2).